This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.

Sequenom’s Petition for En Banc Rehearing Garners Broad Amicus Support

August 28, 2015

Read The Recorder's “Worried Biotech Advocates Swarm to Prenatal Testing Fight”On August 27, twelve amicus briefs were submitted to the Federal Circuit in support of Sequenom’s petition for an en banc rehearing of the panel decision in Ariosa v. Sequenom.  The amici include BIO, the Bioindustry Association, Coalition for 21st Century Medicine, IPO, ILPA, Novartis, and two groups of prominent patent law academics -- a who’s who of biotech industry interests, patent owners’ organizations, and academics who have written extensively in this area of the law. 

The case garnered unusually broad amicus support for good reason: 

Read the recent IPWatchdog  interview with Sequenom counsel Tom Goldstein, co-founder of the SCOTUS blogthe legal issues in this patent appeal will affect individuals across the country. The stakes here are extraordinarily high, with this controversial decision likely to significantly impact the speed of medical innovation, investment in cutting-edge diagnostics, and, most importantly, healthcare opportunities for pregnant women and their children.

The amici included:

  Amicus

  Brief

Biotechnology Industry Association (BIO)

» Download the brief

The Bioindustry Association (BIA)

» Download the brief

Coalition for 21st Century Medicine

» Download the brief

Jeffrey A. Lefstin and Peter S. Menell

» Download the brief

Twenty-Three Law Professors

» Download the brief

Intellectual Property Owners Association (IPO)

» Download the brief

Novartis AG

» Download the brief

New York Intellectual Property Law Association (NYIPLA)

» Download the brief

Paul Gilbert Cole

» Download the brief

Wisconsin Alumni Research Foundation (WARF) and The Marshfield Clinic

» Download the brief

Jyant Technologies Inc.

» Download the brief

Amarantus Bioscience Holdings, Inc., Personalis, Inc., and Population Diagnostics, Inc.

» Download the brief

Also of Interest